Bone Biologics Corp Common Stock
Veridion Score
Composite trend over time
Why is BBLG moving today?
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for BBLG.
BBLG insider activity
Bone Biologics Corp Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for BBLG.
BBLG contract awards, year to date.
Public federal awards linked to this ticker.
BBLG lobbying filings, year to date.
Registered lobbying filings matched to Bone Biologics Corp Common Stock.